When: MACD histogram crossed zero (now at -1.56)

Then: Execute market-on-close trim immediately — no scaled limit orders

Trim 30-50% of position; do NOT initiate short exposure; tighten stop to 104-105 (unit stop ~98); wait for confirmed 102.81 break before incremental reduction; focus on capital preservation over directional betting.

• 30-50% trim is correct defensive action; direction is right, stop at 102.81 is defensible but anchor tighter to 104-105
• Stock still 24% above 200-day moving average - not a broken downtrend
• RSI at 45 is neutral (not oversold), MACD histogram at minus 1.56 is early-cycle deterioration, not climax readings
• Current rally from high 80s to 127 in 14 sessions means potential for violent mean reversion squeezing fresh shorts
• Positive FCF of $4.45 billion is strongest in 4 years despite working-capital-aided OCF conversion jump of 43.5% from 8.1%
• Operating income positive for 4 consecutive quarters; gross margin expanded from 28% to 40% YoY
• Capex moderated from $3.5 billion to $2.56 billion; net debt fell from $41.1 billion to $37.7 billion
• Cash and short-term investments at $29.7 billion
• Tangible book decline from $88.2 billion to $64.5 billion driven by ~$11 billion GAAP loss including ~$12.5 billion non-cash MTM losses on equity holdings, not core operating asset destruction
• Net PP&E at $105.7 billion - operating asset base intact
• Zero INTC-specific news this week; quiet tape near key technicals means volatility expansion risk is elevated without clear directional signal
• 96% no-cut Fed regime is fully priced consensus - markets don't fall on already-priced hawkishness
• Unit-of-risk stop: 1.5x ATR of 6.02 equals ~9 points, putting stop around 98
• 50 SMA at 103-104 acts as key support/resistance to watch
• Do NOT preempt 102.81 break - wait for confirmed close with volume before incremental risk reduction

→ vs aggressive: The beta 2.23 argument cuts both ways - vertical squeezes can be equally violent as drawdowns, especially with stock 24% above long-term trend and potential catalysts (foundry wins, CHIPS Act milestones, 18A yield updates) that haven't been formally priced out.

→ vs aggressive: Patience is a luxury displayed precisely when technicals are deteriorating - momentum unwinds in inflection names are sources of sharpest counter-trend rallies; RSI at 45 and MACD at minus 1.56 are early-cycle readings, not climax readings.

→ vs aggressive: FCF of $4.45 billion is strongest in 4 years; OCF conversion improvement, operating margin inflection, and Capex moderation are data points of an operating business in transition, not deterioration.

→ vs aggressive: Tangible book collapse is non-cash MTM noise on strategic investments (~$12.5 billion in mark-to-market losses) + one-time charges; operating asset base (Net PP&E $105.7 billion) is intact - conflating impairment quarter with operating deterioration is wrong.

→ vs aggressive: Zero INTC-specific news or Polymarket pricing creates compressed information regime where volatility expands unpredictably; initiating shorts into that vacuum is gambling, not risk management.

→ vs aggressive: 96% no-cut Fed regime is already-priced consensus, not fresh headwind; remaining tail risk is dovish surprise that crashes bear trade, not further hawkish surprise that everyone already expects.

TRIM 40% OF LONG EXPOSURE, HOLD STOP AT 102.81 ON REMAINING LOT, INITIATE SMALL TACTICAL HEDGE AT 25-33% OF NORMAL INTC WEIGHT

• Beta: 2.23; stock remains 24% above 200-day moving average
• RSI at 45.84 is mid-zone, not oversold; MACD histogram at minus 1.56 represents early-to-mid-cycle readings, not climax
• MACD histogram deteriorated from plus 3.31 to minus 1.56 in eight sessions
• Price below VWMA with rising volume on sell side
• Sentiment at flat 5 out of 10 with low confidence; no Polymarket pricing Intel binary event
• 50 SMA sits at 102.81; analyst recommends holding stop at this level rather than tightening to 104-105 or ATR-based 98
• 96% no-cut Fed probability acts as a ceiling on multiple expansion; INTC at 51x forward earnings cannot freely re-rate higher in hold-to-hike regime
• Recommend trimming 40% of position (midpoint of 30-50 range)
• Recommend tactical hedge at 25-33% of normal INTC weight to offset residual long exposure, not as directional short bet
• Escalation rules: if 102.81 closes below on daily volume at least 1.5x recent average, cut another 25% and add to hedge; if price reclaims 114.28 with 10 EMA, cut hedge entirely; if foundry or 18A catalyst hits, flatten and reassess
• Hedge macro exposure (Fed risk) with duration exposure at index level, not concentrated single-name short

→ vs aggressive: RSI at 45.84 is mid-zone, not oversold; MACD histogram at minus 1.56 represents early-to-mid-cycle readings, not climax readings. Pressing into a momentum unwind that hasn't climacted yet is buying into a move before it confirms.

→ vs aggressive: Claim that absence of catalyst equals bearish signal is flawed; sentiment vacuum means unscheduled catalyst (foundry win, 18A yield update, CHIPS Act milestone) can violently reprice equity in either direction.

→ vs conservative: Stop placement at 104-105 'slightly inside 50 SMA' is inaccurate since 50 SMA is at 102.81; ATR-based stop at 98 gives back $4-5 of cushion against $6 daily true range, getting wicked out on intraday volatility rather than trend breaks.

→ vs conservative: Absolute prohibition on any short exposure is overcorrecting; a 25-33% hedge to offset residual long after the 40% trim is risk management, not directional speculation.

→ vs conservative: 96% no-cut Fed probability being 'fully priced' still caps multiple expansion; INTC at 51x forward earnings cannot re-rate higher in hold-to-hike regime, so ceiling constrains upside even if it cannot further hurt the stock.